Literature DB >> 36194022

Pathogenic Neisseria Bind the Complement Protein CFHR5 via Outer Membrane Porins.

Wearn-Xin Yee1, Christoph M Tang1, Hayley Lavender1.   

Abstract

Neisseria meningitidis and Neisseria gonorrhoeae are important human pathogens that have evolved to bind the major negative regulator of the complement system, complement factor H (CFH). However, little is known about the interaction of pathogens with CFH-related proteins (CFHRs) which are structurally similar to CFH but lack the main complement regulatory domains found in CFH. Insights into the role of CFHRs have been hampered by a lack of specific reagents. We generated a panel of CFHR-specific monoclonal antibodies and demonstrated that CFHR5 was bound by both pathogenic Neisseria spp. We showed that CFHR5 bound to PorB expressed by both pathogens in the presence of sialylated lipopolysaccharide and enhanced complement activation on the surface of N. gonorrhoeae. Our study furthered our understanding of the interactions of CFHRs with bacterial pathogens and revealed that CFHR5 bound the meningococcus and gonococcus via similar mechanisms.

Entities:  

Keywords:  CFH; CFHR; Neisseria gonorrhoeae; Neisseria meningitidis; complement

Mesh:

Substances:

Year:  2022        PMID: 36194022      PMCID: PMC9584296          DOI: 10.1128/iai.00377-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  64 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Functional significance of factor H binding to Neisseria meningitidis.

Authors:  Muriel C Schneider; Rachel M Exley; Hannah Chan; Ian Feavers; Yu-Hoi Kang; Robert B Sim; Christoph M Tang
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Class-3 porin protein of Neisseria meningitidis: cloning and structure of the gene.

Authors:  S Butcher; M Sarvas; K Runeberg-Nyman
Journal:  Gene       Date:  1991-08-30       Impact factor: 3.688

4.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

5.  FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene.

Authors:  Mihály Józsi; Heiko Richter; Ina Löschmann; Christine Skerka; Friedrich Buck; Ulrike Beisiegel; Anna Erdei; Peter F Zipfel
Journal:  Eur J Hum Genet       Date:  2005-03       Impact factor: 4.246

6.  Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.

Authors:  Jay Lucidarme; Lionel Tan; Rachel M Exley; Jamie Findlow; Ray Borrow; Christoph M Tang
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

7.  Detection and some properties of the sialyltransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrhoeae.

Authors:  R E Mandrell; H Smith; G A Jarvis; J M Griffiss; J A Cole
Journal:  Microb Pathog       Date:  1993-04       Impact factor: 3.738

8.  Dimerization of complement factor H-related proteins modulates complement activation in vivo.

Authors:  Elena Goicoechea de Jorge; Joseph J E Caesar; Talat H Malik; Mitali Patel; Matthew Colledge; Steven Johnson; Svetlana Hakobyan; B Paul Morgan; Claire L Harris; Matthew C Pickering; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

9.  Multiple gonococcal pilin antigenic variants are produced during experimental human infections.

Authors:  H S Seifert; C J Wright; A E Jerse; M S Cohen; J G Cannon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Murine protein H is comprised of 20 repeating units, 61 amino acids in length.

Authors:  T Kristensen; B F Tack
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.